Personal Injury Lawyer Blog & Updates

Xarelto

­

Xarelto Complications and Injuries Stand Out Among FDA Adverse Event Reports Last Year

As thousands of Xarelto injury lawsuits continue to move forward through the court system, a new report highlights the extent of severe problems and bleeding complications that have been linked to this controversial drug. […]

Xarelto Internal Bleeding, Other Injury Lawsuits Moving Toward Trial

The lawyers at Saiontz & Kirk, P.A. represent individuals throughout the U.S. who are pursuing a Xarelto lawsuit after experiencing internal bleeding, hemorrhaging or another bleeding injury caused by the drug maker’s failure to adequately warn about the risks associated with use of the anticoagulant.

It is expected that the first Xarelto trial dates in the federal court system may start around this time next year, but time still remains to determine whether you or a loved one may be eligible for compensation as a result of a Xarelto injury. […]

By |August 4th, 2015|1 Comment

Despite Bleeding Problems, Xarelto Sales Continue to Help J&J Reap Huge Profits

Amid continuing concerns about the risk of uncontrollable bleeding on Xarelto and the lack of an approved reversal agent, Johnson & Johnson indicates that sales of their blockbuster anticoagulant still pushed well past the $1 billion mark last year, helping drive profits even higher for the global pharmaceutical company. […]

By |March 20th, 2015|0 Comments

Xarelto Injury Cases to be Transferred to MDL in Louisiana

With a growing number of Xarelto injury lawsuits continuing to be filed in U.S. District Courts throughout the country, a panel of federal judges has established a coordinated proceeding for the management of the cases, known as an MDL, or multidistrict litigation. […]

By |December 15th, 2014|0 Comments

Xarelto Blood Monitoring May Have Avoided Deaths, Hospitalizations

While Xarelto has been promoted as a superior alternative to warfarin, with the drug makers claiming that it is easier to use and does not require regular blood monitoring, there is increasing evidence that suggests the manufacturers may have been placing their desire for profits before patient safety by making such broad statements. […]

By |November 24th, 2014|0 Comments

Xarelto Class Action Lawsuit-Like Centralization for Bleeding Injury Cases in Federal MDL

UPDATE 12/12/2014: Following a hearing before the U.S. JPML on December 4, an order was issued establishing a Xarelto MDL before U.S. District Judge Eldon Fallon in the Eastern District of Louisiana.

A motion has been filed in the federal court system, seeking to consolidated all Xarelto bleeding injury cases as part of an MDL, or Multidistrict Litigation. While such centralized pretrial proceedings are often referred to as a Xarelto class action lawsuit, each case will remain an individual claim and there are important differences between an MDL and class action. […]

By |October 13th, 2014|1 Comment

Xarelto Reversal Agent Not Fully Researched Before Drug Introduced

Although Xarelto has been promoted as a superior alternative to warfarin (Coumadin), because it is easier to take and requires less monitoring during treatment, there is currently no Xarelto reversal agent available to allow doctors to quickly stop hemorrhages that may develop. […]

By |July 29th, 2014|1 Comment

Xarelto Bleeding Risks Not Adequately Disclosed

In an effort to maximize profits from their new generation blood thinner Xarelto, Johnson & Johnson and Bayer appear to have caused thousands of unnecessary injuries and death by downplaying the risk of uncontrollable bleeding on Xarelto and the lack of an effective reversal agent. […]

Xarelto Lawyers Reviewing Cases Nationwide for Bleeding Injury, Wrongful Death

The product liability lawyers at Saiontz & Kirk, P.A. are now providing free consultations and claim evaluations for individuals and families throughout the United States who may be entitled to financial compensation through an Xarelto lawsuit. […]

By |June 17th, 2014|0 Comments

Class Action Lawsuit for Pradaxa vs MDL

A petition has been filed in federal court calling for the consolidation of all lawsuits over bleeding problems with Pradaxa as part of a multidistrict litigation, or MDL, where the cases would be centralized before one judge for coordinated handling during pretrial proceedings. While many people confuse this process with a Pradaxa class action lawsuit, it is different and each injury or wrongful death claim remains an individual case. […]